XML 106 R84.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity (Details)
12 Months Ended
Oct. 31, 2022
$ / shares
shares
May 07, 2020
shares
Feb. 08, 2019
CNY (¥)
shares
Feb. 08, 2019
USD ($)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
CNY (¥)
shares
Dec. 31, 2020
shares
Dec. 31, 2022
CNY (¥)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Nov. 18, 2022
shares
Jun. 02, 2022
shares
Dec. 31, 2021
USD ($)
shares
Aug. 03, 2021
shares
Mar. 25, 2021
shares
Dec. 31, 2019
shares
Shareholders' Equity (Details) [Line Items]                              
Ordinary stock, shares issued           108,230           108,230      
Convertible promissory note               ¥ 4,038,000 $ 619,000            
Converted ordinary shares         63,250                    
Conversion price (in Dollars per share) | $ / shares         $ 5                    
SPAC Transaction, description         Prior to the closing of the SPAC Transaction, the Company issued 533,000 Class A ordinary shares to the financial advisors and underwriter with fair value of RMB18,713 (US$ 2,868) based on share price of U$5.0 per ordinary share at the time of the transaction.                     
Original shareholders, percentage         70.00%                    
Total cash equivalent (in Yuan Renminbi) | ¥               127,000,000              
Average closing price term         15 days                    
Fair value amount               ¥ 127,000 $ 18,000            
Gross proceeds (in Yuan Renminbi) | ¥           ¥ 664,670                  
Annual general meeting of shareholders description         (i) the adoption of a dual-class share structure, pursuant to which the Company’s authorized share capital shall be re-classified and re-designed into Class A ordinary shares and Class B ordinary shares, with each Class A ordinary share being entitled to one (1) vote and each Class B ordinary share being entitled to ten (10) votes at a meeting of the shareholders or on any resolution of shareholders; and (ii) the authorization to the Company to issue up to 50,000,000 Class A Preferred Shares with such designations, powers, preferences and relative, participation, optional and other rights, if any, and such qualifications, limitations and restrictions as the directors may determine among other matters. Additionally, together with the adoption of a dual-class share structure, 2,625,058 Class A ordinary shares held by Heshine Holdings Limited have been converted into 2,625,058 Class B ordinary shares.                    
Aggregate common shares 794,120                            
Warrants expiration date               Feb. 04, 2024 Feb. 04, 2024            
Warrants exercisable, shares               3,011,850 3,011,850            
Weighted average life         1 year 1 month 6 days                    
Unit purchase option, description     the Company sold to Chardan, for $100, an option to purchase up to 375,000 Units exercisable at $11.50 per Unit (or an aggregate exercise price of $4,312,500) exercisable on the completion of the SPAC Transaction on May 7, 2020. On February 20, 2019, in connection with the underwriters’ election to exercise the over-allotment option in full, the Company issued Chardan an option to purchase up to an additional 56,250 Units exercisable at $11.50 per Unit for no additional consideration. Each Unit consists of one ordinary share, one redeemable warrant and one right (together “UPO”). The unit purchase option may be exercised for cash or on a cashless basis, at the holder’s option, and expires February 5, 2024. For the year ended December 31, 2021, 100,000 UPO have been exercised for 110,000 shares. As of December 31, 2022, the Company had UPO units exercisable for 530,000 Class A ordinary shares with weighted average life of 1.1 years and expiring on February 5, 2024. the Company sold to Chardan, for $100, an option to purchase up to 375,000 Units exercisable at $11.50 per Unit (or an aggregate exercise price of $4,312,500) exercisable on the completion of the SPAC Transaction on May 7, 2020. On February 20, 2019, in connection with the underwriters’ election to exercise the over-allotment option in full, the Company issued Chardan an option to purchase up to an additional 56,250 Units exercisable at $11.50 per Unit for no additional consideration. Each Unit consists of one ordinary share, one redeemable warrant and one right (together “UPO”). The unit purchase option may be exercised for cash or on a cashless basis, at the holder’s option, and expires February 5, 2024. For the year ended December 31, 2021, 100,000 UPO have been exercised for 110,000 shares. As of December 31, 2022, the Company had UPO units exercisable for 530,000 Class A ordinary shares with weighted average life of 1.1 years and expiring on February 5, 2024.                      
Receipt of cash payament (in Dollars) | $         $ 100                    
Unit purchase option (in Dollars) | $         $ 1,286,000                    
Expected volatility, percentage         35.00%                    
Rsk-free interest rate, percentage         2.44%                    
Expected life         5 years                    
Earn-out liability, description         As a result, there was 995,118 earn-out shares required to be issued and the Company classified the related portion of earn-out liability in aggregated of RMB13,106 as shares to be issued in the equity of the Company. As a result, there was 3,540,960 earn-out shares required to be issued and the Company classified the related portion of earn-out liability in aggregated of RMB128,119 as shares to be issued in the equity of the Company. As a result, there was 3,540,960 earn-out shares required to be issued and the Company classified the related portion of earn-out liability in aggregated of RMB200,100 as shares to be issued in the equity of the Company.                
Issuance total           540,960   507,804 507,804     540,960      
Issuances total               93.87% 93.87%            
Total shares               487,314 487,314            
warrants [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Warrants outstanding and exercisable (in Dollars) | $                       $ 6,023,700      
Warrants, description         The Public Warrants became exercisable upon the completion of the SPAC Transaction on May 7, 2020 with exercise price of US$11.5 per full share. The Public Warrants will expire five years from February 5, 2019 (or February 5, 2024).                     
Warrants per share price (in Dollars per share) | $ / shares                 $ 0.01            
Exercise price (in Dollars per share) | $ / shares                 $ 11.5            
Warrants expiration date               Feb. 04, 2024 Feb. 04, 2024            
Initial Public Offering [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Ordinary stock, shares issued     402,983 402,983                      
Converted ordinary shares         602,000                    
Deferred underwriting commission     ¥ 14,131,000 $ 2,166                      
Public warrants, shares           5,653,700                  
Private Placement [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Private warrants, shares           370,000                  
warrants [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Ordinary per share price (in Dollars per share) | $ / shares         $ 16.5                    
Common Stock [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Ordinary stock, shares outstanding   2,249,350                         2,461,983
Ordinary stock, shares issued               19,400,000 19,400,000           2,461,983
Redemption of ordinary shares   212,633                          
Earn-out consideration shares               3,000,000 3,000,000            
Class A ordinary shares [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Ordinary stock, shares outstanding               36,684,668 36,684,668            
Ordinary stock, shares issued           28,219,583 [1]   36,684,668 [1] 36,684,668 [1]   3,240,960 28,219,583 [1]   3,540,960  
Treasury stock, per shares (in Dollars per share) | $ / shares $ 3.01                            
Shares issued           3,000,000 3,000,000     61,500   3,000,000      
Class B ordinary shares [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Ordinary stock, shares outstanding               2,925,058 2,925,058            
Ordinary stock, shares issued           2,625,058 [1]   2,925,058 [1] 2,925,058 [1]   300,000 2,625,058 [1]      
Restricted Stock Units (RSUs) [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Shares issued           2,053,783           2,053,783 2,053,783    
Shares outstanding           2,053,783   716,956 716,956     2,053,783      
Shares forfeited         72,713                    
Shares vested         1,264,114                    
BeeLive [Member] | Class A ordinary shares [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Per share price (in Dollars per share) | $ / shares                 $ 6.68            
Business Combination [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Per share price (in Dollars per share) | $ / shares                 $ 2.98            
BeeLive [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Ordinary stock, shares issued               3,786,719 3,786,719            
Total cash equivalent (in Yuan Renminbi) | ¥               ¥ 175,000,000              
Fair value amount               175,000,000 $ 26,800,000            
BeeLive [Member] | Earn-out Target [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Achieved percentage         93.87%                    
BeeLive [Member] | Class A ordinary shares [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Total cash equivalent (in Yuan Renminbi) | ¥               250,000,000              
Weiliantong [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Total cash equivalent (in Yuan Renminbi) | ¥               ¥ 180,000              
Average closing price term         20 days                    
Weiliantong [Member] | Earn-out Target [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Achieved percentage         100.00%                    
Weiliantong [Member] | Class A ordinary shares [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Ordinary stock, shares issued               3,898,511 3,898,511            
Weiliantong [Member] | Business Combination [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Per share price (in Dollars per share) | $ / shares                 $ 5.13            
Weilaijin [Member] | Class A ordinary shares [Member]                              
Shareholders' Equity (Details) [Line Items]                              
Total cash equivalent (in Yuan Renminbi) | ¥               ¥ 20,800,000              
Shares issued               636,691 636,691            
[1] Ordinary shares and share data have been retroactively restated to give effect to the reverse recapitalization